POLE variants may elicit an intratumoral T cell response in endometrial cancer [56, 57], colorectal cancer [56], meningiomas [58], and high-grade gliomas [33] with an increased number of CD8+ tumor-infiltrating lymphocytes. The gene discussed is POLE; the disease is neoplasm.